Teva: we expect FDA decision on generic lovenox by end of January. We think our application is approvable but we can't guarantee that. Regardless if we get approved at end january or a bit later, we will be one of 3 or 4 players in the generic lovenox business.
Where did you hear/read this last statement? Bill Marth made no comments regarding Lovenox that I heard on the JPM webcast.
Market Data 
Markets 
AI
